Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$27.42 - $43.63 $440,557 - $701,003
-16,067 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$36.48 - $52.22 $20,209 - $28,929
554 Added 3.57%
16,067 $660,000
Q4 2021

Feb 03, 2022

BUY
$33.11 - $55.01 $3,410 - $5,666
103 Added 0.67%
15,513 $674,000
Q3 2021

Oct 27, 2021

SELL
$50.07 - $66.05 $19,627 - $25,891
-392 Reduced 2.48%
15,410 $772,000
Q2 2021

Aug 16, 2021

BUY
$56.61 - $80.46 $3,962 - $5,632
70 Added 0.44%
15,802 $995,000
Q1 2021

May 14, 2021

BUY
$86.23 - $125.19 $94,163 - $136,707
1,092 Added 7.46%
15,732 $1.46 Million
Q4 2020

Feb 09, 2021

BUY
$79.17 - $111.47 $232,680 - $327,610
2,939 Added 25.12%
14,640 $1.31 Million
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $3,522 - $5,802
43 Added 0.37%
11,701 $1.21 Million
Q2 2020

Aug 12, 2020

BUY
$54.33 - $89.52 $114,255 - $188,260
2,103 Added 22.01%
11,658 $922,000
Q1 2020

May 12, 2020

SELL
$49.34 - $68.76 $29,752 - $41,462
-603 Reduced 5.94%
9,555 $553,000
Q4 2019

Feb 12, 2020

BUY
$51.21 - $59.06 $89,617 - $103,355
1,750 Added 20.81%
10,158 $548,000
Q3 2019

Nov 12, 2019

BUY
$40.6 - $57.2 $27,242 - $38,381
671 Added 8.67%
8,408 $440,000
Q2 2019

Aug 13, 2019

BUY
$39.92 - $53.86 $11,616 - $15,673
291 Added 3.91%
7,737 $374,000
Q1 2019

May 03, 2019

BUY
$48.23 - $66.16 $54,258 - $74,430
1,125 Added 17.8%
7,446 $376,000
Q4 2018

Feb 11, 2019

BUY
$55.63 - $73.24 $41,277 - $54,344
742 Added 13.3%
6,321 $375,000
Q3 2018

Nov 13, 2018

BUY
$52.05 - $66.51 $1,353 - $1,729
26 Added 0.47%
5,579 $367,000
Q2 2018

Aug 07, 2018

BUY
$48.33 - $55.64 $45,430 - $52,301
940 Added 20.38%
5,553 $280,000
Q1 2018

May 15, 2018

SELL
$44.44 - $54.39 $10,932 - $13,379
-246 Reduced 5.06%
4,613 $243,000
Q4 2017

Feb 02, 2018

BUY
$37.77 - $47.75 $183,524 - $232,017
4,859
4,859 $226,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $414M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.